Veeva Systems Inc (NYSE:VEEV) stock rose 2.00% (As on March 5, 11:35:06 AM UTC-4, Source: Google Finance) after the company reported fourth quarter results that exceeded analyst expectations across all metrics, as the company demonstrated strong momentum in its AI initiatives and core cloud businesses. Subscription revenues totaled $707.7 million, up 16% YoY. The company ended the year with 1,552 total customers and achieved its $3 billion revenue run rate milestone in early 2025. Non-GAAP operating income for the fourth quarter was $366.5 million, compared to $307.7 million one year ago, an increase of 19% year over year. Non-GAAP net income for the fourth quarter was $346.1 million, compared to $287.9 million one year ago, an increase of 20% year over year. Veeva ended the year with 10 top 20 biopharmas committed to Vault CRM globally and expects about 14 of the top 20 to commit as it continues to execute on its commercial vision. Crossix also had a breakout year, with strong growth in Measurement and Audiences.

Moreover, Veeva Development Cloud and Quality Cloud advanced significantly in the quarter, marked by several top 20 biopharma wins and key progress in newer application areas. In clinical, a top 20 biopharma selected Veeva RTSM as their enterprise standard. Safety momentum continued with Veeva’s sixth top 20 win and its first top 20 biopharma live on Workbench and Signal. In Quality, Veeva LIMS made significant progress and remains on track for its first top 20 biopharma go-live at two manufacturing sites in 2026.

VEEV in the fourth quarter of FY26 has reported the adjusted earnings per share of $2.06, beating the analysts’ estimates for the adjusted earnings per share of $1.93. The company had reported the adjusted revenue growth of 16 percent to $836 million in the fourth quarter of FY26, beating the analysts’ estimates for revenue of $810.67 billion.

The company issued first quarter fiscal 2027 guidance with adjusted EPS of $2.13-$2.14, above the consensus of $2.07. First quarter revenue guidance of $855-858 million exceeded analyst estimates of $846 million, with a midpoint of $856.5 million. Q1 FY27 Non-GAAP operating income is expecting to be between $378 and $381 million.

For the full fiscal year 2027, Veeva expects adjusted EPS of approximately $8.85, above the $8.59 consensus, and revenue of $3.585-$3.600 billion versus the $3.57 billion estimate. The revenue guidance midpoint of $3.593 billion surpasses analyst expectations. FY 27 Non-GAAP operating income is expecting to be of about $1,590 million